5mg Min + DermaRoll 1.5mm Weekly + Keto/Salicyclic alternative day + 0.5 mg Dut. Norwood 6, should I go to 2.5 mg Dut? 33 Year old
    7/24/2026

    From the encyclopedia
    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    Dutasteride →

    5-alpha reductase inhibitor that blocks both enzyme types, a stronger DHT blocker than finasteride

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Minoxidil (oral) 5mg 4 weeks
    💧 DermaRoll (topical) 1.5mm weekly 4 weeks
    💧 Ketoconazole/Salicylic (topical) alternative day 4 weeks
    💊 Dutasteride (oral) 0.5mg 4 weeks
    • RLT Cap 4 weeks
    the tone is 😞 negative.

    Other terms

    The user is considering increasing their dose of Dutasteride from 0.5 mg to 2.5 mg while using Minoxidil, DermaRoll, and other treatments for hair regrowth after multiple hair transplants. Many responses suggest accepting baldness or using a hair system instead of continuing with medications.
    View this post in the Community →

    Similar Community Posts Join

    6 / 6 results

    Related Research

    6 / 6 results

      research Oral Presentations

      July 2012 in “International Journal of Trichology”
      This article discusses various aspects of hair and scalp health, ancient philosophical perspectives on hair, and causes of hair disorders in children, without reporting new clinical results.

      research Managing patterned hair loss – a hair raising task!

      October 2021 in “Cosmoderma”
      This review summarizes existing knowledge on diffuse and patterned alopecia, emphasizing recent advancements in treatment beyond FDA-approved options, but it reports no new clinical findings.

      research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies

      December 2025 in “IP Indian Journal of Clinical and Experimental Dermatology”
      This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.

      research Dissolving microneedles: an advanced approach for transdermal drug delivery

      January 2025 in “Journal of Pharmaceutical Research Science & Technology”
      This review explores the potential, challenges, and recent advancements of dissolving microneedles in drug delivery, summarizing their varied applications and current limitations without providing new clinical results.